Skip to main content

Advertisement

SpringerLink
Log in

Leukemic and lymphomatous meningitis: incidence, prognosis and treatment

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Neoplastic meningitis (NM) is a common problem in neuro-oncology occurring in approximately 5% of all patients with cancer. Notwithstanding frequent focal signs and symptoms in NM, NM is a disease affecting the entire neuraxis and therefore staging and treatment need encompass all cerebrospinal fluid (CSF) compartments. Central nervous system (CNS) staging of NM includes contrast enhanced cranial computerized tomography (CE-CT) or magnetic resonance imaging (MR-Gd), contrast enhanced spine magnetic resonance imaging (MR-S) or computerized tomographic myelography (CT-M) and radionuclide CSF flow study (FS). Treatment of NM involves involved-field radiotherapy of bulky or symptomatic disease sites and intra-CSF drug therapy. The inclusion of concomitant systemic therapy may benefit patients with NM and may obviate the need for intra-CSF chemotherapy. At present, intra-CSF drug therapy is confined to three chemotherapeutic agents (i.e. methotrexate, cytosine arabinoside and thio-TEPA) administered by a variety of schedules either by intralumbar or intraventricular drug delivery. Although treatment of NM is palliative with an expected median patient survival of 4 to 6 months, it often affords stabilization and protection from further neurologic deterioration in patients with NM. In patients with leukemia or lymphoma, prophylaxis of the CNS is used (utilizing a combination of high-dose systemic chemotherapy and intra-CSF chemotherapy) for patients at high risk as defined by specific tumor-related laboratory markers. Using such a risk-stratified approach, the late occurrence of CNS relapse has decreased dramatically attesting to the value of CNS prophylaxis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. LM DeAngelis (1998) ArticleTitleCurrent diagnosis and treatment of leptomeningeal metastasis J Neuro Oncol 38 245–252 Occurrence Handle10.1023/A:1005956925637

    Article  Google Scholar 

  2. JG Kaplan TG DeSouza A Farkash B Shafran D Pack F Rehman J Fuks R Portenoy (1990) ArticleTitleLeptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias J Neuro Oncol 9 225–229

    Google Scholar 

  3. RJ Oostenbrugge ParticleVan A Twijnstra (1999) ArticleTitlePresenting features and value of diagnostic procedures in leptomeningeal metastases Neurology 53 382–385 Occurrence Handle10430430

    PubMed  Google Scholar 

  4. Surapaneni UR, Cortes JE, Thomas D et al.: Central Nervous System Relapse in Adults with Acute Lymphoblastic Leukemia. Cancer 94(3): 2002.

  5. C Haioun C Besson E Lepage et al. (2000) ArticleTitleIncidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients Ann Oncol 11 685–690 Occurrence Handle10.1023/A:1008394827806 Occurrence Handle10942056

    Article  PubMed  Google Scholar 

  6. A Hollender S Kvaloy O Nome et al. (2002) ArticleTitleCentral nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model Ann Oncol 13 1099–1107 Occurrence Handle10.1093/annonc/mdf175 Occurrence Handle12176790

    Article  PubMed  Google Scholar 

  7. HM Kantarijian S O'Brien TL. Swmith et al. (2000) ArticleTitleResults of treatment with hyper-CVAD, a dose-intensive regimen, in adult a cute lymphocytic leukemia J Clin Oncol 18 547–561 Occurrence Handle10653870

    PubMed  Google Scholar 

  8. HM Kantarjian RS Walters TL Smith et al. (1988) ArticleTitleIdentification of risk groups for development of central nervous system leukemia in adults with acutelymphocytic leukemia Blood 72 1784–1789 Occurrence Handle3052630

    PubMed  Google Scholar 

  9. PC Bishop WH Wilson D Pearson J Janik ES Jaffe PC Elwood (1999) ArticleTitleCNS involvement in primary mediastinal large B-cell lymphoma J Clin Oncol 17 2479–2485 Occurrence Handle10561312

    PubMed  Google Scholar 

  10. L Recht DJ Straus C Cirrincione HT Thaler JB Posner (1988) ArticleTitleCentral nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis Am J Med 84 425–435 Occurrence Handle10.1016/0002-9343(88)90262-8 Occurrence Handle3348245

    Article  PubMed  Google Scholar 

  11. EL Bollen RE Brouwer S Hamers J Hermans M Kluin SU Sankatsing RV A-Tjak MV Charvat JC Kluin-Nelemans (1997) ArticleTitleCentral nervous system relapse in non-Hodgkin's lymphoma: A single-center study of 532 patients Arch Neurol 54 854–859 Occurrence Handle9236574

    PubMed  Google Scholar 

  12. J Ersboll HB Schultz BL Thomsen N Keiding NI Nissen (1985) ArticleTitle Meningeal involvement in non-Hodgkin's lymphoma : symptoms, incidence, risk factors and treatment Scand J Haematol 35 487–496 Occurrence Handle4089528

    PubMed  Google Scholar 

  13. JP Litam F Cabanillas TL Smith GP Bodey EJ. Freireich (1979) ArticleTitleCentral nervous system relapse in malignant lymphomas: risk factors and implications for prophylaxis Blood 54 1249–1257 Occurrence Handle508936

    PubMed  Google Scholar 

  14. R Liang E Chiu SL Loke (1990) ArticleTitleSecondary central nervous system involvement by non-Hodgkin's lymphoma: the risk factors Hematol Oncol 8 141–145 Occurrence Handle2373491

    PubMed  Google Scholar 

  15. K Besien ParticleVan CS Ha S Murphy P McLaughlin A Rodriguez K Amin A Forman J Romaguera F Hagemeister A Younes C Bachier A Sarris KS Sobocinski JD Cox F Cabanillas (1998) ArticleTitleRisk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma Blood 91 1178–1184 Occurrence Handle9454747

    PubMed  Google Scholar 

  16. MC Chamberlain PA Kormanik (1997) ArticleTitleNon-AIDS related lymphomatous meningitis: Combined modality therapy Neurology 49 1728–1731 Occurrence Handle9409381

    PubMed  Google Scholar 

  17. LJ Levitt DM Dawson DS Rosenthal et al. (1980) ArticleTitleCNS involvement in the non-Hodgkin's lymphoma Cancer 45 545–552 Occurrence Handle6986199

    PubMed  Google Scholar 

  18. O'Neill BP.: Neurologic Complications of Hodgkin's disease and the non-Hodgkin's lymphomas: Cancer Neurol Clin Prac 371–384.

  19. HH Reiche (2003) Leukemia. In Cancer Neurology in Clinical Practice Humana Press Inc. Totowa, New Jersey 355–369

    Google Scholar 

  20. Recht L, Mrugala M. Neurologic complications of hematologic neoplasms. Neurologic Clinics, W.B. Saunders Company. 2003, Vol. 21, No. 1. pp 87–105.

  21. RW Wolk SR Masse R Conklin EJ. Freireich (1974) ArticleTitleThe incidence of central nervous system leukemia in adults with acute leukemia Cancer 33 863 Occurrence Handle4521890

    PubMed  Google Scholar 

  22. DJ Stewart MJ Keating KB McCredie et al. (1981) ArticleTitleNatural history of central nervous system acute leukemia in adults Cancer 47 184–196 Occurrence Handle7459807

    PubMed  Google Scholar 

  23. RJ Meyer PP Ferreira J. Cuttner et al. (1980) ArticleTitleCentral nervous system involvement at presentation in acute granulocytic leukemia. a prospective cytocentrifuge study Am J Med 68 691–694 Occurrence Handle10.1016/0002-9343(80)90255-7 Occurrence Handle6929653

    Article  PubMed  Google Scholar 

  24. D Thomas J Cortes FJ Giles et al. (2001) ArticleTitleThe modified hyper-CBAD regimen in newly diagnosed adult acute lymphoblastic leukemia (ALL) Blood 98 IssueIDsuppl. 1 590a

    Google Scholar 

  25. J Cortes (2001) ArticleTitleCentral nervous system involvement in adult acute lymphocytic leukemia Hematol Oncol Clin North Am. 15 145–162 Occurrence Handle10.1016/S0889-8588(05)70203-3 Occurrence Handle11253605

    Article  PubMed  Google Scholar 

  26. J Cash KM Fehir MS Pollack (1987) ArticleTitleMeningeal involvement in early stage chronic lymphocytic leukemia Cancer 59 798–800 Occurrence Handle3802037

    PubMed  Google Scholar 

  27. SC Cramer JA Glaspy JT Efird DN Louis (1996) ArticleTitleChronic lymphocytic leukemia and the central nervous system: a clinical and pathological study Neurology 46 19–25 Occurrence Handle8559372

    PubMed  Google Scholar 

  28. JH Bower JE Hammack SK McDonnell A Tefferi (1997) ArticleTitleThe neurologic complications of B-cell chronic lymphocytic leukemia Neurology 48 407–412 Occurrence Handle9040730

    PubMed  Google Scholar 

  29. LE Abrey J Yahalom DeAngelis (2000) ArticleTitleTreatment for primary CNS lymphoma: the next step J Clin Oncol 18 3144–3150 Occurrence Handle10963643

    PubMed  Google Scholar 

  30. U Herrilinger M Schabet W Brugger RD Kortmann W Kuker et al. (2002) ArticleTitleGerman Cancer Society Neuro-Oncology Working Group NOA-03 Multicenter Trial of Single-Agent High-Dose Methotrexate for Primary CNS Lymphoma Ann Neurol 51 247–252 Occurrence Handle10.1002/ana.10102 Occurrence Handle11835382

    Article  PubMed  Google Scholar 

  31. BJ Fisher W Sieferheld C Schultz L DeAngelis SC Schold W Curran (2001) ArticleTitleSecondary analysis of RTOG 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma with chemotherapy and hyperfractionated radiotherapy Int J Rad Oncol Biol Phy 51 IssueID3 Suppl 1 166–177 Occurrence Handle10.1016/S0360-3016(01)02125-3

    Article  Google Scholar 

  32. HM Kantarjian T Smith E Estey et al. (1992) ArticleTitlePrognostic significance of elevated serum beta 2-microglobulin levels in acute lymphocytic leukemia Am J Med. 93 599–604 Occurrence Handle10.1016/0002-9343(92)90191-D Occurrence Handle1466355

    Article  PubMed  Google Scholar 

  33. F Ravandi J Cortes Z Estrov et al. (2002) ArticleTitleCD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia Leuk Res 26 643–649 Occurrence Handle10.1016/S0145-2126(01)00188-6 Occurrence Handle12008081

    Article  PubMed  Google Scholar 

  34. GM Mavlight SE Stuckey FF Cabanillas et al. (1980) ArticleTitleDiagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination N Engl J Med 303 718–722 Occurrence Handle6157089

    PubMed  Google Scholar 

  35. MC Chamberlain (1998) ArticleTitleLeptomeningeal metastases: a review of evaluation and treatment J Neuro Oncol 37 271–84 Occurrence Handle10.1023/A:1005976926058

    Article  Google Scholar 

  36. M Chamberlain (1996) leptomeningeal metastases V Levin (Eds) Cancer in the Nervous System Churchill Livingstone New York 282–290

    Google Scholar 

  37. W Wasserstrom J Glass J Posner (1982) ArticleTitleDiagnosis and treatment of leptomeningeal metastases from solid tumors experience with 90 patients Cancer 49 759–772 Occurrence Handle6895713

    PubMed  Google Scholar 

  38. SA Grossman MJ Krabak (1999) ArticleTitleLeptomeningeal carcinomatosis Cancer Treat Rev 25 IssueID2 103–119 Occurrence Handle10.1053/ctrv.1999.0119 Occurrence Handle10395835

    Article  PubMed  Google Scholar 

  39. J Murray F Greco S Wolff et al. (1983) ArticleTitleNeoplastic meningitis; marked variations of cerebrospinal fluid composition in the absence of extradural block Am J Med 75 289–294 Occurrence Handle10.1016/0002-9343(83)91207-X Occurrence Handle6881181

    Article  PubMed  Google Scholar 

  40. B Burger M Zimmermann G Mann et al. (2003) ArticleTitleDiagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture J Clini Oncol 21 IssueID2 184–188 Occurrence Handle10.1200/JCO.2003.04.096

    Article  Google Scholar 

  41. WR Wasserstrom MK Schwartz M Fleisher et al. (1981) ArticleTitleCerebrospinal fluid biochemical markers in central nervous system tumors: a review Ann Clin Lab Sci 11 IssueID3 239–251 Occurrence Handle6166240

    PubMed  Google Scholar 

  42. AP Zanten ParticleVan A Twijnstra AA Hart et al. (1986) ArticleTitleCerebrospinal fluid lactate dehydrogenase activities in patients with central nervous system metastases Clin Chim Acta 161 IssueID3 259–268 Occurrence Handle10.1016/0009-8981(86)90009-4 Occurrence Handle3802533

    Article  PubMed  Google Scholar 

  43. GG Klee RD Tallman JR Goellner et al. (1986) ArticleTitleElevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis Mayo Clin Proc 61 IssueID1 9–13 Occurrence Handle3510343

    PubMed  Google Scholar 

  44. A Twijnstra AP Zanten Particlevan AA Hart et al. (1987) ArticleTitleSerial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours J Neurol Neurosurg Psychiatry 50 IssueID3 313–320 Occurrence Handle3559613

    PubMed  Google Scholar 

  45. A Twijnstra DV Ongerboer AP Zanten Particlevan et al. (1989) ArticleTitleSerial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors J Neuro Oncol 7 IssueID1 57–63 Occurrence Handle10.1007/BF00149379

    Article  Google Scholar 

  46. G Stockhammer W Poewe S Burgstaller et al. (2000) ArticleTitleVascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis Neurology 54 IssueID8 1670–1676 Occurrence Handle10762512

    PubMed  Google Scholar 

  47. MC Chamberlain (1998) ArticleTitleCytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers Neurology 50 IssueID4 1173–1175 Occurrence Handle9566421

    PubMed  Google Scholar 

  48. JA Garson HB Coakham JT Kemshead et al. (1985) ArticleTitleThe role of monoclonal antibodies in brain tumour diagnosis and cerebrospinal fluid (CSF) cytology J Neuro Oncol 3 IssueID2 165–171

    Google Scholar 

  49. A Hovestadt SC Henzen-Logmans CJ Vecht (1990) ArticleTitleImmunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis Br J Cancer 62 IssueID4 653–654 Occurrence Handle2223585

    PubMed  Google Scholar 

  50. W Boogerd TM Vroom P Heerde Particlevan et al. (1988) ArticleTitleCSF cytology versus immunocytochemistry in meningeal carcinomatosis J Neurol Neurosurg Psychiatry 51 IssueID1 142–145 Occurrence Handle2832546

    PubMed  Google Scholar 

  51. MJ Kersten LM Evers PL Dellemijn et al. (1996) ArticleTitleElevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies Blood 87 1985–1999 Occurrence Handle8634448

    PubMed  Google Scholar 

  52. GM Jeffery CM Frampton HM Legge DN Hart (1990) ArticleTitleCerebrospinal fluid B2-microglobulin levels in meningeal involvement by malignancy Pathology 22 20–23 Occurrence Handle2194155

    PubMed  Google Scholar 

  53. RJ Oostenbrugge ParticleVan AH Hopman FC Ramaekers et al. (1998) ArticleTitleIn situ hybridization: a possible diagnostic aid in leptomeningeal metastasis J Neuro Oncol 38 IssueID2–3 127–133 Occurrence Handle10.1023/A:1005926624303

    Article  Google Scholar 

  54. ES Cibas MG Malkin JB Posner et al. (1987) ArticleTitleDetection of DNA abnormalities by flow cytometry in cells from cerebrospinal fluid Am J Clin Pathol 88 IssueID5 570–577 Occurrence Handle3673940

    PubMed  Google Scholar 

  55. RJ Oostenbrugge ParticleVan AH Hopman JW Arends et al. (1998) ArticleTitleThe value of interphase cytogenetics in cytology for the diagnosis of leptomeningeal metastases Neurology 51 IssueID3 906–908 Occurrence Handle9748058

    PubMed  Google Scholar 

  56. CH Rhodes MJ Glantz L Glantz et al. (1996) ArticleTitleA comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis Cancer 77 IssueID3 543–548 Occurrence Handle10.1002/(SICI)1097-0142(19960201)77:3<543::AID-CNCR17>3.0.CO;2-4 Occurrence Handle8630963

    Article  PubMed  Google Scholar 

  57. CH Rhodes MJ Glantz L Glantz A Lekos GD Sorenson C Honsinger NB Levy (1996) ArticleTitleA comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis Cancer 77 543–548 Occurrence Handle10.1002/(SICI)1097-0142(19960201)77:3<543::AID-CNCR17>3.0.CO;2-4 Occurrence Handle8630963

    Article  PubMed  Google Scholar 

  58. S Biesterfeld B Bernhard S Bamborschke et al. (1993) ArticleTitleDNA single cell cytometry in lymphocytic pleocytosis of the cerebrospinal fluid Acta Neuropathol (Berl) 86 IssueID5 428–432

    Google Scholar 

  59. TM Cheng BP O'Neill BW Scheithauer et al. (1994) ArticleTitleChronic meningitis: the role of meningeal or cortical biopsy Neurosurgery 34 IssueID4 590–595 Occurrence Handle8008155

    PubMed  Google Scholar 

  60. J Glass M Melamed N Chernik et al. (1979) ArticleTitleMalignant cells in cerebrospinal fluid (CSF) the meaning of a positive CSF cytology Neurology 29 1369–1375 Occurrence Handle573381

    PubMed  Google Scholar 

  61. M Chamberlain A Sandy G. Press (1990) ArticleTitleLeptomeningeal metastasis a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain Neurology 40 435–438

    Google Scholar 

  62. G Sze S Soletsky R Bronen et al. (1989) ArticleTitleMR imaging of the cranial meninges with emphasis on contrast enhancements and meningeal carcinomatosis AJNR 10 965–975 Occurrence Handle2505542

    PubMed  Google Scholar 

  63. DA Collie RJ Sellar JP Steyn RE Cull (1999) ArticleTitleThe diagnostic yield of magnetic resonance imaging (MRI) of the brain and spine requested by general practitioners: comparison with hospital clinicians Br J Gen Pract 49 559–561 Occurrence Handle10621993

    PubMed  Google Scholar 

  64. JM Gomori N Heching T. Siegal (1998) ArticleTitleLeptomeningeal metastases: evaluation by gadolinium enhanced spinal magnetic resonance imaging J Neuro Oncol 36 55–60 Occurrence Handle10.1023/A:1005783507544

    Article  Google Scholar 

  65. MC Chamberlain (1995) ArticleTitleComparative spine imaging in leptomeningeal metastases Neuro-Oncol 23 233–238 Occurrence Handle10.1007/BF01059954

    Article  Google Scholar 

  66. K Kim S Ho P Weinberg et al. (1982) ArticleTitleSpinal leptomeningeal infiltration by systemic cancer myelographic features AJR 139 361–365 Occurrence Handle6979894

    PubMed  Google Scholar 

  67. E Kramer S Rafto R Packer et al. (1991) ArticleTitleComparison of myelography with CT follow-up versus gadolinium MRI for subarachnoid metastatic disease in children Neurology 41 46–50

    Google Scholar 

  68. M Chamberlain J Corey-Bloom (1991) ArticleTitleLeptomeningeal metastases indium-DTPA CSF flow studies Neurology 41 1765–1769 Occurrence Handle1944906

    PubMed  Google Scholar 

  69. MC Chamberlain P Kormanik (1996) ArticleTitlePrognostic significance of indium-DTPA CSF flow studies Neurology 46 IssueID6 1674–1677 Occurrence Handle8649568

    PubMed  Google Scholar 

  70. JA Paulus GM Bos B Lowenberg MJ Bent ParticleVan Den (1998) ArticleTitleTreatment results and the prognosis in patients with localization of non-Hodgkin's-lymphoma in the central nervous system Ned Tijdschr Geneeskd 142 IssueID3 2196–2200 Occurrence Handle9864481

    PubMed  Google Scholar 

  71. F Bokstein A Lossos IS Lossos T Siegal (2002) ArticleTitleCentral nervous system relapse of systemic non-Hodgkin's lymphoma: results of treatment based on high-dose methotrexate combination chemotherapy Leuk Lymphoma 43 587–593 Occurrence Handle10.1080/10428190290012092 Occurrence Handle12002763

    Article  PubMed  Google Scholar 

  72. T Philip C Guglielmi A Hagenbeek R Somers H Lelie ParticleVan der D Bron P Sonneveld C Gisselbrecht JY Cahn JL Harousseau et al. (1995) ArticleTitleAutologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma N Engl J Med 333 1540–1545 Occurrence Handle10.1056/NEJM199512073332305 Occurrence Handle7477169

    Article  PubMed  Google Scholar 

  73. CD Williams R Pearce G Taghipour ES Green T Philip AH Goldstone (1994) ArticleTitleAutologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome–a report by the European Bone Marrow Transplant Lymphoma Registry J Clin Oncol 12 2415–2422 Occurrence Handle7964958

    PubMed  Google Scholar 

  74. JC Alvarnas RS Negrin SJ Horning WW Hu GD Long JR Schriber K Stockerl-Goldstein K Tierney R Wong KG Blume NJ Chao (2000) ArticleTitleHigh-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma Biol Blood Marrow Transplant 6 352–358 Occurrence Handle10905773

    PubMed  Google Scholar 

  75. MJ Glantz S LaFollette KA Jaeckle W Shapiro L Swinnen JR Rozental S Phuphanich LR Rogers JC Gutheil T Batchelor D Lyter M Chamberlain BL Maria C Schiffer R Bashir D Thomas W Cowpens SB Howell (1999) ArticleTitleRandomized trial of a slow release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis J Clin Oncol 17 3110–3116 Occurrence Handle10506606

    PubMed  Google Scholar 

  76. M Chamberlain L Dirr (1993) ArticleTitleInvolved field radiotherapy and intra-ommaya methotrexate/ara-C in patients with AIDS-related lymphomatous meningitis J Clin Onc 11 1978–1984

    Google Scholar 

  77. MC Chamberlain P Kormanik M Glantz (1998) ArticleTitleRecurrent primary central nervous system lymphoma complicated by lymphomatous meningitis Oncol Rep 5 521–523 Occurrence Handle9468593

    PubMed  Google Scholar 

  78. S Yoshida K Morii M Watanabe T Saito (2000) ArticleTitleCharacteristic features of malignant lymphoma with central nervous system involvement Surg Neurol 53 163–167 Occurrence Handle10.1016/S0090-3019(99)00186-X Occurrence Handle10713195

    Article  PubMed  Google Scholar 

  79. MC Chamberlain PA Kormanik (1997) ArticleTitleComplications associated with intraventricular chemotherapy in patients with leptomeningeal metastases J Neurosurg 87 694–699 Occurrence Handle9347977

    PubMed  Google Scholar 

  80. MC Chamberlain PA Kormanik (1997) ArticleTitlePrognostic significance of coexistent bulky metastatic central nervous system disease in patients with leptomeningeal metastases Arch Neurol 54 1364–1368 Occurrence Handle9362983

    PubMed  Google Scholar 

  81. R Blasberg C Patlak J Fenstermacher (1975) ArticleTitleIntrathecal chemotherapy brain tissue profiles after ventriculo-cisternal perfusion Pharm Exp Ther 195 73–83

    Google Scholar 

  82. IT Magrath TB Haddy MA Adde (1996) ArticleTitleTreatment of patients with high-grade non-Hodgkin's lymphomas and central nervous system involvement: is radiation an essential component of therapy Leuk Lymphoma 21 99–105 Occurrence Handle8907276

    PubMed  Google Scholar 

  83. F Balis D Poplack (1989) ArticleTitleCentral nervous system pharmacology of antileukemic drugs Amer J Pediatr Hemat/Oncol 11 74–86

    Google Scholar 

  84. J Collins (1983) ArticleTitlePharmacokinetics of intraventricular administration J Neuro-Oncol 1 283–291 Occurrence Handle10.1007/BF00165710

    Article  Google Scholar 

  85. T Siegal A Lassos MR Pfeffer (1994) ArticleTitleLeptomeningeal metastases: analysis of 31 patients with sustained off-therapy response following combined-modality therapy Neurology 44 1463–1469 Occurrence Handle8058150

    PubMed  Google Scholar 

  86. W Boogerd AAM Hart Sande ParticleVan der et al. (1991) ArticleTitleMeningeal carcinomatosis breast cancer Prognostic factors and influence of treatment. Cancer 67 1685–1695

    Google Scholar 

  87. L Giannone F Greco J Hainsworth (1986) ArticleTitleCombination intraventricular chemotherapy for meningeal neoplasia J Clin Oncol 4 68–73 Occurrence Handle3079822

    PubMed  Google Scholar 

  88. R Hitchens D Bell R Woods et al. (1987) ArticleTitleA prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis J Clin Oncol 5 1655–1662 Occurrence Handle3309199

    PubMed  Google Scholar 

  89. SA Grossman DM Finkelstein JC Ruckdeschel et al. (1993) ArticleTitleRandomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis J Clin Oncol 11 561–569 Occurrence Handle8445432

    PubMed  Google Scholar 

  90. W Shapiro D Young B Mehta (1975) ArticleTitleMethotrexate distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections N Engl J Med 293 161–166 Occurrence Handle806016

    PubMed  Google Scholar 

  91. CS Rabkin F Yellin (1994) ArticleTitleCancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1 J Natl Cancer Inst 16; 86 IssueID16 1711–1716

    Google Scholar 

  92. A Cingolani R Gastaldi L Fassone F Pierconti ML Giancola M Martini A Luca ParticleDe A Ammassari C Mazzone E Pescarmona G Gaidano LM Larocca A Antinori (2000) ArticleTitleEpstein–Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas J Clin Oncol 18 3325–3330 Occurrence Handle11013271

    PubMed  Google Scholar 

  93. BO Taiwo (2000) ArticleTitleAIDS-related primary CNS lymphoma: a brief review AIDS Read 10 486–491 Occurrence Handle10967810

    PubMed  Google Scholar 

  94. LM DeAngelis E Wong M Rosenblum H Furneaux (1992) ArticleTitleEpstein–Barr virus in acquired immune deficiency syndrome (AIDS) and non-AIDS primary central nervous system lymphoma Cancer 70 1607–1611 Occurrence Handle1325277

    PubMed  Google Scholar 

  95. J Desai RJ Mitnick DH Henry J Llena JA Sparano (1999) ArticleTitlePatterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-Hodgkin lymphoma Cancer 86 1840–1847 Occurrence Handle10.1002/(SICI)1097-0142(19991101)86:9<1840::AID-CNCR28>3.0.CO;2-C Occurrence Handle10547559

    Article  PubMed  Google Scholar 

  96. MC Chamberlain PA Kormanik (1999) ArticleTitleAIDS-related central nervous system lymphomas J Neuro Oncol 43 269–276 Occurrence Handle10.1023/A:1006262720665

    Article  Google Scholar 

  97. LE Raez P Patel L Feun A Restrepo WA Raub SuffixJr. PA Cassileth (1998) ArticleTitleNatural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL) Crit Rev Oncol 9 199–208

    Google Scholar 

  98. JD Goldstein DW Dickson FG Moser AD Hirschfeld K Freeman JF Llena B Kaplan L Davis (1991) ArticleTitlePrimary central nervous system lymphoma in acquired immune deficiency syndrome A clinical and pathologic study with results of treatment with radiation. Cancer 67 2756–2765

    Google Scholar 

  99. C Balmaceda JJ Gaynor M Sun JT Gluck LM DeAngelis (1995) ArticleTitleLeptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications Ann Neurol 38 202–209 Occurrence Handle10.1002/ana.410380212 Occurrence Handle7654067

    Article  PubMed  Google Scholar 

  100. MC Chamberlain (2003) ArticleTitleNeoplastic meningitis-related encephalopathy: prognostic significance. American Academy of Neurology, Honolulu, Hawaii, March 29–April 5, 2003 Neurology 60 IssueID5 A17–A18 Occurrence Handle10.1159/000070452

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Southern California/Norris Comprehensive Cancer Center and Hospital, Los Angeles, CA

    Marc C. Chamberlain

  2. Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021-6007, USA

    Craig Nolan & Lauren E. Abrey

Authors
  1. Marc C. Chamberlain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Craig Nolan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lauren E. Abrey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lauren E. Abrey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

C. Chamberlain, M., Nolan, C. & E. Abrey, L. Leukemic and lymphomatous meningitis: incidence, prognosis and treatment. J Neurooncol 75, 71–83 (2005). https://doi.org/10.1007/s11060-004-8100-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-004-8100-y

Keywords

Search

Navigation